Robert R. Goodwin

Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT.

Part of Angiotech Pharmaceuticals, Inc., STS Biopolymers, Inc. develops, manufactures, and licenses custom polymer-based coatings for medical devices. The company is based in Henrietta, NY. STS Biopolymers was acquired by Angiotech Pharmaceuticals, Inc. on December 04, 2003 for $23 million.